학술논문
Piperlongumine synergistically enhances the antitumour activity of sorafenib by mediating ROS-AMPK activation and targeting CPSF7 in liver cancer
Document Type
Article
Author
Source
In Pharmacological Research March 2022 177
Subject
Language
ISSN
1043-6618